It looks like my post about FCSC three weeks ago was spot-on. From #msg-63888868:
Although you will probably argue vociferously that the company has a great future, behind closed doors you probably feel that you were conned: you took a huge risk, the drug got FDA approval, but the share price is a big yawn. Eventually, you will have to admit (privately, if not publicly) that this drug has no chance whatsoever to capture more than a minuscule share of the market for aesthetic medicine.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.